Orthotopic liver transplantation: treatment of choice in cirrhotic patients with hepatocellular carcinoma?
Moreno
P
P
Liver Transplant Unit, C.S.U. Bellvitge, University of Barcelona, Spain.
Jaurrieta
E
E
Figueras
J
J
Benasco
C
C
Rafecas
A
A
Fabregat
J
J
Torras
J
J
Casanovas
T
T
Casais
L
L
D000704:Analysis of Variance; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000601:surgery*; D016461:Chemoembolization, Therapeutic; D004317:Doxorubicin / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D008113:Liver Neoplasms / Q000150:complications / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D016031:Liver Transplantation / Q000401:mortality; D009367:Neoplasm Staging; D011184:Postoperative Period; D011379:Prognosis; D012008:Recurrence; D015996:Survival Rate; D013997:Time Factors
D004317:Doxorubicin